PhRMA senior director on 340B program: 'Hospitals abuse the program to boost their profits at the expense of patients'
PhRMA director of public affairs on 340B exploitation: ‘Evidence shows that 340B entities markup medicines by as much 1,000% or more’
HealthLeaders editor on 340B: ‘We continue to have serious concerns about persistent and often illegal abuse of 340B’
Iowa board files charges against FarmaKeio, citing FDA and California actions
North Carolina Board of Pharmacy schedules July meeting with live stream option
Alerts Sign-up
